Circular Genomics is the global leader in the use of circular RNA as a novel biomarker to power precision medicine to improve the diagnosis and treatment of neurological and psychiatric conditions

Bespoke, global consulting firm based in Silicon Valley offering clients in medtech, biotechnology, drg discovery services, life sciences and hi-tech sensing/imaging, general consulting, strategy, fundraising, execution, stage-gate-driven product development, commercial launch, international expansion and M&A/IPO advisory services

Rebus Biosystems (formerly Optical Biosystems) has developed an automated omics solution that provides subcellular resolution of biological molecules directly in and across large tissue sections. Customizable assays allow you to focus on the targets that matter most to your research, whether that be in neuroscience, immunology, oncology, infectious disease, development, or any other area of biology. We are driving the next wave of the omics revolution, multiplexed biology in its true spatial context at high resolution.

Clearbridge Biophotonics FPM Inc. is commercializing a Caltech IP estate in computational imaging technology that will radically innovate conventional microscopy. Fourier Ptychographic Microscopy ("FPM") delivers wider field of view, all in focus, lens aberration correction, post-acquisition re-focusing, label-free approaches, and high density array microscopy across a range of fields. Sold to Cellavision. Clearbridge Health (CBH-Singapore) is redefining Asia's medical Insights and personalized medical care. CBH is the first clinical group in Asia to offer end-to-end precision diagnostic capabilities, developing and deploying non-invasive tests for identification and management of illnesses. Clearbridge Accelerator is one of Singapore’s leading incubation and investment firm that invests in global deep-technology companies with a focus on healthcare and infosecurity.

Lucidity Inc., is a management consulting firm headquartered in Denver, Colorado offering services to global clients in medical devices, clinical diagnostics, drug discovery, biotechnology and global health sectors. Lucidity brings clarity from inception to market - leveraging 23 years of global experience of its founder, Paul Sargeant PhD, with strategy & business planning, fundraising (VC/PE), best-in-class market research and technology development (NPD, MRD, PSD), general and executive management, business development and worldwide commercial launch.Recent assignments:Interim CEO drug discovery services startup - raised $1M capital, recognition of first global revenues, entity establishment, strategic plan, operational management, marketing plan deployment, team creation.Multi $BN Global Philanthropy - developed, tested and deployed a Target product Profile business process, used internally with 8 teams, closed 15 TPP’s, deployed foundation-wide TPP & market research initiatives, brought in key partner firms Ipsos & TNS Health.Cloud-based ultrasound medical device company - developed investor presentation ~2 months, raised successive non-dilutive rounds at $1M and $5MEstablished Medical device company - led technology development effort, re-designed product team, repeat engagement for fundraising, KOL recruitment and commercializationMulti-billion medical device - conducted successive rounds of market research, worked with executive team to identify acquirer, successful close of transaction at $2.6BNWound-healing technology startup - assisted with successful fundraising, FDA submissions, identification of commercial channels

Management of an international team of 14 Group/Senior Product Managers and Project Managers with responsibilities for a specific genomics product/technology portfolio. Product groups include siRNA, miRNA, Vector-based RNAi, cDNA/ORF's, PCR, qPCR instruments, plastics and reagents. Involved in acquisition integration of two recently acquired companies. Responsible for the new product development process from concept to final product launch and beyond. Created project management function to work cross-functionally to manage multiple international projects and develoepd stagegate-driven new product development process.

De-novo development of a downstream marketing team for image-guided surgery products and imaging devices (CT and MRI). Global commercialization tools development, strategy-setting, market research and analysis, 4-P programs.

Development of international commercialization team for novel medical device for the blood bank. Market segmentation, analysis and MRD/PRD input to product development team. Creation of commercialization plan for product roll-out on an international basis.

Tripos is an accelerated drug discovey services provider to global pharma and biotech industries. Led the commercial efforts for LeadQuest compound libraries, development of LeadScreen product, and provided market direction for chemistry synthesis services to major pharma worldwide. Responsible for over 600% revenue growth.

Responsible for tri-state territory of over $3M in total sales. Grew from base of $1.7M. 'President's Club top 5 of 70 reps twice.Integral in Sanofi Paster integration post-acquisition; product rationalizations, synergies, market positioning